Enrollment in drug study ends

Filed under: Health & Safety: Babies

Sanofi-Aventis, the maker of the antibiotic Ketek, announced Friday that it will discontinue the use of children in their drug studies. The drug has been linked to liver failure in adults.

The company will not acknowledge any wrong doing in the clinical studies involving children. The manufacturer will only comment that it is only trying to comply with FDA requirements regarding the testing of children.

The use of Ketek has been shown to cause an increase in liver failure of almost 4 times the normal rate in adults. The end of these trials is a relief. Any testing that puts a minor at risk is not worth the harm that child might incur.

ReaderComments (Page 1 of 1)


Flickr RSS



AdviceMama Says:
Start by teaching him that it is safe to do so.